New York City’s health department is issuing a warning about a concerning increase in cases of the mpox virus within the city. Previously known as monkeypox, the virus has seen a significant uptick in reported cases since October, prompting health officials to urge medical professionals to remain vigilant ahead of the summer months when transmission rates may rise.
In a recent advisory, health officials highlighted a sharp rise in monthly mpox cases, with numbers peaking at 51 cases in January. The majority of these cases were reported among men who have sex with men, with Black and Hispanic individuals between the ages of 25 and 44 being the most affected demographic group. Despite most cases being mild, there were instances where individuals required hospitalization.
The U.S. Centers for Disease Control underscores the presence of two strains of the virus – Clade I and Clade II. While Clade II typically results in mild symptoms and a high survival rate, Clade I, which is prevalent in Central Africa, has shown higher mortality rates in some outbreaks. To mitigate the spread of the virus, health officials emphasize the importance of vaccination, noting that a significant portion of the population recommended to receive the vaccine remains unvaccinated.
Health officials are advocating for increased vaccination efforts and providing guidance for healthcare providers on testing protocols and preventative measures. The Department of Health advises individuals at potential risk of exposure to seek out the JYNNEOS vaccine and implement precautions to minimize transmission and alleviate symptoms. By following these recommendations and staying informed on the latest guidance, individuals and healthcare providers can help curb the spread of the mpox virus in New York City.